Immunological lessons learnt from patients transplanted with fully mismatched stem cells

Fully HLA-mismatched stem cells from human fetal livers were transplanted into 17 infants and two fetuses to treat severe combined immunodeficiency disease in 1976-2000. Donor cell engraftment and immunological reconstitution were obtained in 14/19 patients, three of whom have been extensively and r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunologic research 2007-01, Vol.38 (1-3), p.201-209
Hauptverfasser: Touraine, Jean-Louis, Plotnicky, Hélène, Roncarolo, Maria-Grazia, Bacchetta, Rosa, Gebuhrer, Lucette
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 209
container_issue 1-3
container_start_page 201
container_title Immunologic research
container_volume 38
creator Touraine, Jean-Louis
Plotnicky, Hélène
Roncarolo, Maria-Grazia
Bacchetta, Rosa
Gebuhrer, Lucette
description Fully HLA-mismatched stem cells from human fetal livers were transplanted into 17 infants and two fetuses to treat severe combined immunodeficiency disease in 1976-2000. Donor cell engraftment and immunological reconstitution were obtained in 14/19 patients, three of whom have been extensively and repeatedly studied immunologically during prolonged follow-up. T-cells were derived totally from donor cells; B-cells and antigen-presenting cells (APC) remained mainly of host origin. Due to class I and II mismatches between T-cells and all other cells (APC, B-cells, virus-infected target cells), limitations in the defense against infections in vivo and in T-cell functions in vitro (helper and cytotoxic activities) were predicted; however, these did not occur. Anti-tetanus toxoid responses (including specific antibody production) developed despite HLA disparities between T-cells and B-cells or APC in the chimeric children. Similarly, cytotoxic T-cells (of donor HLA phenotype) recognized host Epstein-Barr virus-infected target cells. Recognition of antigenic peptide by T-cells under these conditions involved presentation by host allogeneic HLA molecules and not by self HLA antigens. Tolerance to donor antigens was acquired by clonal deletion; tolerance to host antigens existed despite the presence of many host-reactive T-cells and involved clonal anergy.
doi_str_mv 10.1007/s12026-007-0002-6
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02660488v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19532020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-fc2d5e9a40c37adb8513be1edc2cda71d27af989fbc849c58bbe3cdab44f72e43</originalsourceid><addsrcrecordid>eNqFkc9LwzAUx4Mobk7_AC9SPAgeqkmaNM1xDH8MBl4UdgtpmrqOtJlJquy_N6VDwYuB8B4vn-_jvXwBuETwDkHI7j3CEOdpTOOFOM2PwBRRylPIKD0GU4gpSzFj6wk4834LIcoJyU7BBDGOWJROwXrZtn1njX1vlDSJ0d7bzscoXReS2tk22cnQ6C74JDjZ-Z2RXdBV8tWETVL3xuyTtvGtDGoTqz7oNlHaGH8OTmppvL44xBl4e3x4XTynq5en5WK-SlXGUUhrhSuquSRQZUxWZUFRVmqkK4VVJRmqMJM1L3hdqoJwRYuy1Fl8KQmpGdYkm4Hbse9GGrFzTSvdXljZiOf5Sgy1uGYOSVF8osjejOzO2Y9e-yDi6MO0stO29yIvMkIZp_-CKDLx62EEr_-AW9u7Li48MAWPZ-iGRkg5673T9c-cCIrBSDEaKYZ0MFLkUXN1aNyXra5-FQfnsm8Zapow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195899995</pqid></control><display><type>article</type><title>Immunological lessons learnt from patients transplanted with fully mismatched stem cells</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Touraine, Jean-Louis ; Plotnicky, Hélène ; Roncarolo, Maria-Grazia ; Bacchetta, Rosa ; Gebuhrer, Lucette</creator><creatorcontrib>Touraine, Jean-Louis ; Plotnicky, Hélène ; Roncarolo, Maria-Grazia ; Bacchetta, Rosa ; Gebuhrer, Lucette</creatorcontrib><description>Fully HLA-mismatched stem cells from human fetal livers were transplanted into 17 infants and two fetuses to treat severe combined immunodeficiency disease in 1976-2000. Donor cell engraftment and immunological reconstitution were obtained in 14/19 patients, three of whom have been extensively and repeatedly studied immunologically during prolonged follow-up. T-cells were derived totally from donor cells; B-cells and antigen-presenting cells (APC) remained mainly of host origin. Due to class I and II mismatches between T-cells and all other cells (APC, B-cells, virus-infected target cells), limitations in the defense against infections in vivo and in T-cell functions in vitro (helper and cytotoxic activities) were predicted; however, these did not occur. Anti-tetanus toxoid responses (including specific antibody production) developed despite HLA disparities between T-cells and B-cells or APC in the chimeric children. Similarly, cytotoxic T-cells (of donor HLA phenotype) recognized host Epstein-Barr virus-infected target cells. Recognition of antigenic peptide by T-cells under these conditions involved presentation by host allogeneic HLA molecules and not by self HLA antigens. Tolerance to donor antigens was acquired by clonal deletion; tolerance to host antigens existed despite the presence of many host-reactive T-cells and involved clonal anergy.</description><identifier>ISSN: 0257-277X</identifier><identifier>EISSN: 1559-0755</identifier><identifier>DOI: 10.1007/s12026-007-0002-6</identifier><identifier>PMID: 17917026</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Antigens ; Clonal Anergy ; Cytotoxicity, Immunologic ; Female ; Hematopoietic Stem Cell Transplantation ; Hematopoietic Stem Cells - immunology ; Histocompatibility Testing ; HLA Antigens - immunology ; Humans ; Immune system ; Infant ; Life Sciences ; Living Donors ; Male ; Peptides ; Severe Combined Immunodeficiency - surgery ; Stem cells ; T cell receptors ; T-Lymphocytes - immunology ; T-Lymphocytes, Cytotoxic - immunology ; Transplantation Tolerance ; Transplants &amp; implants ; Treatment Outcome</subject><ispartof>Immunologic research, 2007-01, Vol.38 (1-3), p.201-209</ispartof><rights>Humana Press Inc. 2007</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-fc2d5e9a40c37adb8513be1edc2cda71d27af989fbc849c58bbe3cdab44f72e43</citedby><cites>FETCH-LOGICAL-c391t-fc2d5e9a40c37adb8513be1edc2cda71d27af989fbc849c58bbe3cdab44f72e43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17917026$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.inrae.fr/hal-02660488$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Touraine, Jean-Louis</creatorcontrib><creatorcontrib>Plotnicky, Hélène</creatorcontrib><creatorcontrib>Roncarolo, Maria-Grazia</creatorcontrib><creatorcontrib>Bacchetta, Rosa</creatorcontrib><creatorcontrib>Gebuhrer, Lucette</creatorcontrib><title>Immunological lessons learnt from patients transplanted with fully mismatched stem cells</title><title>Immunologic research</title><addtitle>Immunol Res</addtitle><description>Fully HLA-mismatched stem cells from human fetal livers were transplanted into 17 infants and two fetuses to treat severe combined immunodeficiency disease in 1976-2000. Donor cell engraftment and immunological reconstitution were obtained in 14/19 patients, three of whom have been extensively and repeatedly studied immunologically during prolonged follow-up. T-cells were derived totally from donor cells; B-cells and antigen-presenting cells (APC) remained mainly of host origin. Due to class I and II mismatches between T-cells and all other cells (APC, B-cells, virus-infected target cells), limitations in the defense against infections in vivo and in T-cell functions in vitro (helper and cytotoxic activities) were predicted; however, these did not occur. Anti-tetanus toxoid responses (including specific antibody production) developed despite HLA disparities between T-cells and B-cells or APC in the chimeric children. Similarly, cytotoxic T-cells (of donor HLA phenotype) recognized host Epstein-Barr virus-infected target cells. Recognition of antigenic peptide by T-cells under these conditions involved presentation by host allogeneic HLA molecules and not by self HLA antigens. Tolerance to donor antigens was acquired by clonal deletion; tolerance to host antigens existed despite the presence of many host-reactive T-cells and involved clonal anergy.</description><subject>Antigens</subject><subject>Clonal Anergy</subject><subject>Cytotoxicity, Immunologic</subject><subject>Female</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Hematopoietic Stem Cells - immunology</subject><subject>Histocompatibility Testing</subject><subject>HLA Antigens - immunology</subject><subject>Humans</subject><subject>Immune system</subject><subject>Infant</subject><subject>Life Sciences</subject><subject>Living Donors</subject><subject>Male</subject><subject>Peptides</subject><subject>Severe Combined Immunodeficiency - surgery</subject><subject>Stem cells</subject><subject>T cell receptors</subject><subject>T-Lymphocytes - immunology</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>Transplantation Tolerance</subject><subject>Transplants &amp; implants</subject><subject>Treatment Outcome</subject><issn>0257-277X</issn><issn>1559-0755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkc9LwzAUx4Mobk7_AC9SPAgeqkmaNM1xDH8MBl4UdgtpmrqOtJlJquy_N6VDwYuB8B4vn-_jvXwBuETwDkHI7j3CEOdpTOOFOM2PwBRRylPIKD0GU4gpSzFj6wk4834LIcoJyU7BBDGOWJROwXrZtn1njX1vlDSJ0d7bzscoXReS2tk22cnQ6C74JDjZ-Z2RXdBV8tWETVL3xuyTtvGtDGoTqz7oNlHaGH8OTmppvL44xBl4e3x4XTynq5en5WK-SlXGUUhrhSuquSRQZUxWZUFRVmqkK4VVJRmqMJM1L3hdqoJwRYuy1Fl8KQmpGdYkm4Hbse9GGrFzTSvdXljZiOf5Sgy1uGYOSVF8osjejOzO2Y9e-yDi6MO0stO29yIvMkIZp_-CKDLx62EEr_-AW9u7Li48MAWPZ-iGRkg5673T9c-cCIrBSDEaKYZ0MFLkUXN1aNyXra5-FQfnsm8Zapow</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Touraine, Jean-Louis</creator><creator>Plotnicky, Hélène</creator><creator>Roncarolo, Maria-Grazia</creator><creator>Bacchetta, Rosa</creator><creator>Gebuhrer, Lucette</creator><general>Springer Nature B.V</general><general>Humana Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7QL</scope><scope>7QO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope></search><sort><creationdate>20070101</creationdate><title>Immunological lessons learnt from patients transplanted with fully mismatched stem cells</title><author>Touraine, Jean-Louis ; Plotnicky, Hélène ; Roncarolo, Maria-Grazia ; Bacchetta, Rosa ; Gebuhrer, Lucette</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-fc2d5e9a40c37adb8513be1edc2cda71d27af989fbc849c58bbe3cdab44f72e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Antigens</topic><topic>Clonal Anergy</topic><topic>Cytotoxicity, Immunologic</topic><topic>Female</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Hematopoietic Stem Cells - immunology</topic><topic>Histocompatibility Testing</topic><topic>HLA Antigens - immunology</topic><topic>Humans</topic><topic>Immune system</topic><topic>Infant</topic><topic>Life Sciences</topic><topic>Living Donors</topic><topic>Male</topic><topic>Peptides</topic><topic>Severe Combined Immunodeficiency - surgery</topic><topic>Stem cells</topic><topic>T cell receptors</topic><topic>T-Lymphocytes - immunology</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>Transplantation Tolerance</topic><topic>Transplants &amp; implants</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Touraine, Jean-Louis</creatorcontrib><creatorcontrib>Plotnicky, Hélène</creatorcontrib><creatorcontrib>Roncarolo, Maria-Grazia</creatorcontrib><creatorcontrib>Bacchetta, Rosa</creatorcontrib><creatorcontrib>Gebuhrer, Lucette</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Immunologic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Touraine, Jean-Louis</au><au>Plotnicky, Hélène</au><au>Roncarolo, Maria-Grazia</au><au>Bacchetta, Rosa</au><au>Gebuhrer, Lucette</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunological lessons learnt from patients transplanted with fully mismatched stem cells</atitle><jtitle>Immunologic research</jtitle><addtitle>Immunol Res</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>38</volume><issue>1-3</issue><spage>201</spage><epage>209</epage><pages>201-209</pages><issn>0257-277X</issn><eissn>1559-0755</eissn><abstract>Fully HLA-mismatched stem cells from human fetal livers were transplanted into 17 infants and two fetuses to treat severe combined immunodeficiency disease in 1976-2000. Donor cell engraftment and immunological reconstitution were obtained in 14/19 patients, three of whom have been extensively and repeatedly studied immunologically during prolonged follow-up. T-cells were derived totally from donor cells; B-cells and antigen-presenting cells (APC) remained mainly of host origin. Due to class I and II mismatches between T-cells and all other cells (APC, B-cells, virus-infected target cells), limitations in the defense against infections in vivo and in T-cell functions in vitro (helper and cytotoxic activities) were predicted; however, these did not occur. Anti-tetanus toxoid responses (including specific antibody production) developed despite HLA disparities between T-cells and B-cells or APC in the chimeric children. Similarly, cytotoxic T-cells (of donor HLA phenotype) recognized host Epstein-Barr virus-infected target cells. Recognition of antigenic peptide by T-cells under these conditions involved presentation by host allogeneic HLA molecules and not by self HLA antigens. Tolerance to donor antigens was acquired by clonal deletion; tolerance to host antigens existed despite the presence of many host-reactive T-cells and involved clonal anergy.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>17917026</pmid><doi>10.1007/s12026-007-0002-6</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0257-277X
ispartof Immunologic research, 2007-01, Vol.38 (1-3), p.201-209
issn 0257-277X
1559-0755
language eng
recordid cdi_hal_primary_oai_HAL_hal_02660488v1
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Antigens
Clonal Anergy
Cytotoxicity, Immunologic
Female
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells - immunology
Histocompatibility Testing
HLA Antigens - immunology
Humans
Immune system
Infant
Life Sciences
Living Donors
Male
Peptides
Severe Combined Immunodeficiency - surgery
Stem cells
T cell receptors
T-Lymphocytes - immunology
T-Lymphocytes, Cytotoxic - immunology
Transplantation Tolerance
Transplants & implants
Treatment Outcome
title Immunological lessons learnt from patients transplanted with fully mismatched stem cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T03%3A59%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunological%20lessons%20learnt%20from%20patients%20transplanted%20with%20fully%20mismatched%20stem%20cells&rft.jtitle=Immunologic%20research&rft.au=Touraine,%20Jean-Louis&rft.date=2007-01-01&rft.volume=38&rft.issue=1-3&rft.spage=201&rft.epage=209&rft.pages=201-209&rft.issn=0257-277X&rft.eissn=1559-0755&rft_id=info:doi/10.1007/s12026-007-0002-6&rft_dat=%3Cproquest_hal_p%3E19532020%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195899995&rft_id=info:pmid/17917026&rfr_iscdi=true